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Background:O2 pathways in animal hemoglobins and myoglobins are controversial.
Results: Ligands enter and exit sperm whale Mb and Cerebratulus lacteus Hb by completely different pathways.
Conclusion:Rational mutagenesis mapping can identify ligandmigration pathways and provides experimental benchmarks for
testing molecular dynamics simulations.
Significance: Globins can use either a polar gate or an apolar tunnel for ligand entry.
Although molecular dynamics simulations suggest multiple
interior pathways for O2 entry into and exit from globins, most
experiments indicate well defined single pathways. In 2001, we
highlighted the effects of large-to-small amino acid replace-
ments on rates for ligand entry and exit onto the three-dimen-
sional structure of sperm whale myoglobin. The resultant map
argued strongly for ligand movement through a short channel
from the heme iron to solvent that is gated by the distal histidine
(His-64(E7)) near the solvent edge of the porphyrin ring. In this
work, we have applied the same mutagenesis mapping strategy
to the neuronal mini-hemoglobin from Cerebratulus lacteus
(CerHb), whichhas a large internal tunnel from the heme iron to
the C-terminal ends of the E and H helices, a direction that is
180° opposite to the E7 channel. Detailed comparisons of the
new CerHbmap with expanded results for Mb show unambigu-
ously that the dominant (>90%) ligand pathway in CerHb is
through the internal tunnel, and the major (>75%) ligand path-
way in Mb is through the E7 gate. These results demonstrate
that: 1) mutagenesis mapping can identify internal pathways
when they exist; 2) molecular dynamics simulations need to be
refined to address discrepancies with experimental observa-
tions; and 3) alternative pathways have evolved in globins to
meet specific physiological demands.
Most animal myoglobins (Mbs)4 and red cell hemoglobins
(Hbs) bind O2 reversibly for storage or transport. The ligand
covalently coordinates to the heme iron atom and is fully
enclosed by amino acid side chains to prevent exposure to sol-
vent and oxidation. In crystal structures, there is often no obvi-
ous pathway for ligand migration into the distal portion of the
heme pocket shown in Fig. 1A. In 1966 after publication of the
first high resolution globin structure, Perutz and Matthews (1)
suggested thatO2 entersHb andMbby a short channel gated by
the distal histidine at the E7 helical position, and this idea was
later supported by outward movement of the distal histidine
when large ligands were bound to Mb (2, 3). However, in 1969,
internal cavities were discovered in sperm whale myoglobin
(SwMb) capable of binding xenon at moderate pressures (10
atm (4–9)). This observation led Petsko and co-workers (5) and
others in the 1980s to suggest that instead of passing through
the His(E7) gate, diatomic gases may enter and exit globins
through apolar pathways between helices and the loops con-
necting them.
The current evidence for movement of photodissociated
ligands out of the distal pocket and into theXe1 andXe4 sites in
SwMb is clear and comes from time-resolved spectroscopic
methods (10–13) and from direct observations by time-re-
solved x-ray crystallography (14–20). However, thesemeasure-
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ments cannot detect whether ligands enter and exit the protein
from these transient positions. Ligand movements out of the
protein involve overcoming larger activation barriers, and the
resultant unstable transition states cannot be seen directly.
Consequently, entry and exit pathways have to be inferred
either theoretically from molecular dynamics (MD) simula-
tions or experimentally from the effects of mutagenesis on
kinetic parameters for ligand entry and escape.
In 1990, Elber and Karplus (21) carried out locally enhanced
simulations of ligand movement in SwMb and observed multi-
ple trajectories for ligand migration out of the protein. In 2010,
Elber (22) reviewed the most recent computational literature,
which still indicates that there are multiple ligand pathways in
animal myoglobins and hemoglobins and that the channel
gated by the distal histidine is only a minor route for entry and
exit (23–31).
In 1994, Huang and Boxer (32) used an elegant random
mutagenesis protocol to create and screen a library of 1,500
single point mutants. Mutations were identified from colonies
that produced lysates containing Mbs with kinetic parameters
significantly different (50%) from those of wild-type (WT)
controls. Roughly 10% of the mutants examined showed differ-
ences, and a structural model of Mb was constructed to high-
light the positions of the mutants showing altered kinetic
parameters. In addition to positions near the bound ligand,
other regions were highlighted, including interior positions
near the Xe cavities and the C-terminal portion of the H helix.
These results were interpreted to mean that multiple pathways
for CO and O2 entry and exit exist, supporting the conclusions
from the initial MD simulations (32).
Building on Huang and Boxer’s strategy, our group explored
the E7 gate and Xe cavity pathways in SwMb by a rational
mutagenesis mapping strategy in which small (Gly or Ala) and
large (Phe or Trp) mutations were constructed in ligand-acces-
sible cavities, along the major trajectories specified by the MD
simulations and at some of the positions found in the random
mutagenesis screen (13). Each of 90 different mutants was pro-
duced in milligram quantities; geminate and bimolecular rate
parameters for ligand binding were measured with pure pro-
teins; and in many cases, crystal structures were determined
(33–38).
Our mutagenesis mapping results strongly indicate the fol-
lowing: 1) although O2 can move from the binding pocket into
the Xe cavities, it must return to the distal pocket to exit the
protein, and 2) themajor pathway (75%) for O2 entry and exit
is the short channel that opens by outward movement of the
distal histidine side chain. The discrepancy between our
mutagenesis map and that of Huang and Boxer (32) is not as
great as it first appears. The largest changes in their random
mutagenesis map were observed at or near the E7 gate, and
most of the effects observed at remote positions can be ratio-
nalized as false positives due to mutations that destabilize the
Mb structure, leading to lysates containing partially unfolded
proteins with exposed or weakly bound heme groups (i.e.many
of the Pro substitutions (32)). The multiple trajectories
obtained from MD simulations are harder to reconcile and
imply that either we cannot “find” internal pathways with a
rationalmutagenesismapping strategy or themodels and inter-
action potentials used in the simulations cannot accurately
define ligand movements into solvent.
In 2002, Pesce et al. (39) reported the structure of the mini-
hemoglobin from the sea worm Cerebratulus lacteus (CerHb).
CerHb is a neuronal O2 storage protein, which surrounds the
axons and brain of the Nemertean worm, and it rapidly releases
O2 when the worm burrows into sand and becomes anaerobic
while searching for prey (40). The analysis of the CerHb crystal
structure revealed the presence of an apolar tunnel leading
from the distal pocket to solvent, with an exit point between the
E and H helices created by the loss of the N-terminal A helix
(Fig. 1B). This tunnel was suggested to be the major route of
entry and exit for O2 binding, and later work indicated that this
“open” channel accounts for the very large association rate con-
stants for O2 and NO binding to CerHb (200–300 M1 s1),
which are close to the values expected for diffusion-controlled
processes (41).
Our initial mutagenesis and Xe binding studies of CerHb
supported the original idea of Pesce et al. (39) that the internal
tunnel is the major ligand pathway (39, 42, 43). Thus, we have
used CerHb as a counter example to SwMbwhere the histidine
gate mechanism for O2 binding appears to apply. However,
Orlowski and Nowak (44) carried out simulations with CerHb
and, as with SwMb, obtainedmultiple trajectories with the apo-
lar tunnel being only one of them.
To resolve this discrepancy and determine whether the
experimental mutagenesis mapping strategy can identify inter-
nal pathways, we constructed and examined the O2, CO, and
NO ligand binding properties of 120 different mutants of
CerHb. Rates of ligand entry and exit for this library of CerHb
variants were compared with results for an expanded library of
SwMbmutants, which extends the results of Scott et al. (13) to
regions near the ends of the E and H helices.
Our goals were: 1) to verify the mutagenesis mapping strat-
egy; 2) to define experimentally the ligand pathways in the two
proteins; 3) to compare the results toMD simulations; and 4) to
provide benchmarks for future theoretical work.
EXPERIMENTAL PROCEDURES
Hb and Mb Sample Preparations—WT and mutant recom-
binant CerHbs were expressed and purified as described previ-
ously using a synthetic gene with codon usage optimized for
expression in Escherichia coli (39, 41). TheWTSwMb gene and
expression plasmid (pMb413) were constructed by Springer
and Sligar (45) to optimize codon usage in E. coli. All new
mutants were constructed using this gene in a pUC19-based
expression vector and the Stratagene PCR-based QuikChange
site-directed mutagenesis kit (Stratagene, La Jolla, CA). Purifi-
cation was achieved as described previously by Springer and
Sligar (45, 46) and modified by Carver et al. (47). TheWT con-
trol and the mutant Mbs have an extra N-terminal Met residue
and a D122N substitution for crystallization in the P6 space
group, neither of which has an effect on ligand binding (48). All
experiments to determine rate constants were carried out in
0.1 M phosphate buffer, pH 7.0, 1.0 mM EDTA, 20 °C.
Measurement of Rate Constants for Ligand Association (kO2 ,
kCO , and kNO ) and Dissociation (kO2 and kCO)—CO association
time courses were measured after complete laser photolysis of
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SwMbCO and CerHbCO samples containing various [CO]
under pseudo first order conditions as described previously
(42). The association rate constants for NO binding to deoxy-
SwMb and deoxy-CerHb were measured using a flow-flash
multimixing apparatus and a 500-ns dye laser (42, 43, 49). In
these experiments, SwMbCO or CerHbCO samples in deoxy-
genated buffer were mixed with various concentrations of NO
and then photolyzed 10–20 ms after mixing, allowing mea-
surement of time courses for NO binding to the newly formed
deoxy-SwMb or deoxy-CerHb without the limitations of the
low quantum yields of CerHbNOand SwMbNOcomplexes. O2
association and dissociation time courses were measured after
complete laser photolysis of SwMbCO and CerHbCO samples
in O2/COmixtures using a 500-ns dye laser as described previ-
ously (42, 49, 50). Experimental procedures and fitting routines
to obtain values for kO2 , and kO2 (kO2 indicates oxygen associ-
ation rate constant; and kO2 indicates oxygen dissociation rate
constant) from analyses of the fast bimolecular binding and
slow O2 displacement phases have been described in previous
work (42, 49, 50).
Measurement of Geminate Recombination—Time courses
for internal geminate CO and O2 recombination within CerHb
and SwMb were measured at 436 nm after excitation with a
7-ns excitation pulse from a Lumonics YAG-laser system, using
a Tektronix TDS3052 digitizing oscilloscope with nanosecond
time resolution. Experimental procedures and fitting routines
were followed as described previously (13, 42). Sample time
courses are shown in Figs. 5–7. The results were analyzed and
interpreted in terms of the previously published mechanisms
for ligand binding to SwMb (13) and CerHb (42, 43), as
described below.
Analysis of Bimolecular and Geminate Rate Parameters—In
Scott et al. (13), bimolecular and geminate O2 bindings to
SwMb were analyzed in terms of the three-step, side-path
model shown in Fig. 1A. The rate constants for intramolecular
rebinding, escape, andmovement through the protein between
sites B andCwere obtained by fitting sets of time courses to this
model using numerical integration algorithms described by
Scott andGibson (12). The geminate rebinding time courses for
WT SwMb and many of the mutants can also be fitted well by
the sum of two exponential processes and an offset reflecting
the amount of escape to solvent. In this analysis, the rate of the
fast phase equals kbond  kBC  kescape, the total fraction of
geminate recombination, Fgem,total, equals kbond/(kbond 
kescape), and the fraction of the slow phase, Fgem,slow, approxi-
mately equals kBC/(kbond  kBC  kescape), allowing an estima-
tion of all three rate parameters (13). It should be noted that a
simple two-step reaction analysis, using the correct Fgem,total,
provides the same value of kentry and an only slightly larger
kescape value.
The side-path mechanism was chosen for analysis of SwMb
data because both Xe binding and mutations that fill the Xe1
and Xe4 cavities collapse the time courses to a single rapid
phase with little or no change in the total fraction of geminate
rebinding (12, 13). Similar results were obtained for geminate
ligand rebinding to WT Scapharca inaequivalvis Hbl, where
again, Xe binding and Phe and Trp replacements in internal
cavities caused little change in the total fraction of geminate
recombination (51). In the case of HbA subunits, single gemi-
nate phases for CO rebinding are observed at room tempera-
ture on nanosecond time scales and indicate that there are no
side path C states, and again, the E7 channel appears to be the
path for ligand entry and escape (49, 52). Thus, the scheme
shown in Fig. 1A appears to apply to most animal hemoglobins
with a tertiary and distal pocket structure similar to that of
SwMb.
The fraction of photodissociated ligands that geminately
rebind after photolysis is defined solely by kbond/(kbondkescape)
in the SwMb scheme in Fig. 1A. There is no dependence on the
rates of interconversion of the C and B sites, which only affect
the rates and amplitudes of the slower geminate phases. Thus,
regardless of the complexity of the internal movements, the
overall bimolecular rate constant for ligand binding to SwMb
under physiological conditions ([C], [B], d[C]/dt, and d[B]/dt
0) is given by (13) Equation 1,
kX  kentryFgeminate: Fgeminate
kbond
kbond kescape
(Eq. 1)
where X stands for O2, CO, or NO. In the scheme shown in Fig.
1A, kentry represents the second order rate constant for forma-
tion of state B, starting with ligand in the solvent phase. Values
of kentry for O2 entry in SwMb were calculated from kO2 /
Fgeminate and are listed in Table 3 for new mutants and in Scott
et al. (13) for the remaining 90 variants.
It is important to note that the experimental values of Fgem
aremodel-independent and depend only on an accurate defini-
tion of the absorbance change for the total amount of geminate
recombination. Thus, Equation 1 can also be used empirically
to estimate the rate of entry into any globin, including CerHb,
where in Fig. 1B binding involves a linear sequential set of
ligandmovements. As discussed by Scott et al. (13), the steady-
state expression for kX using a linear scheme is still kX  kentry
Fgem, but in this case kentry represents the bimolecular rate of
entry into the first discrete site in the protein, which, in the case
of CerHb, would be the apolar tunnel. However, if the barriers
along the tunnel and from the tunnel into the distal pocket are
small compared with bond formation, the mechanism reduces
to a two-step process with a single geminate intermediate.
Under these conditions, Fgem can again be approximated as
kbond/(kbond kescape).
In the case of CO binding to CerHb, there is evidence of a
barrier between the tunnel and the distal pocket implying a
linear three-step scheme. However, this extra complexity is
only evident at low temperatures (53) or at room temperature
when restrictions in the tunnel are completely removed as is
observed in the L86A mutant (43).
Whenmovement into and through the tunnel is restricted by
mutagenesis, the geminate time courses become single expo-
nentials and are readily analyzed as a simple two-step scheme
(Equation 2),
kgem kbond kescape: Fgeminate
kbond
kbond kescape
kbond kgemFgeminate: kescape kgem(1 Fgeminate) (Eq. 2)
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We used the expressions in Equations 1 and 2 to estimate
values of kentry , kescape, and kbond for CO binding to all of the
mutants of CerHb examined (Tables 1 and 4 and supplemen-
tal Tables S1–S4). These estimations, although empirical,
are the simplest and closest to the observed experimental
data, making the maps shown in Fig. 4 experimentally
defined and not model-dependent.
NO Association and the Validity of Using kentry and kescape—
In principle, the calculated values of kentry and kescape should be
used to map the ligand pathways quantitatively because these
parameters factor out the differences in reactivity (kbond values)
between theO2, CO, andNO. The values of these entry and exit
parameters should be the same for all three diatomic gases
because of their similar sizes and diffusion constants at room
temperature. In the case of CO binding to WT CerHb, the rel-
ative errors in these calculated parameters are very large
because the extent of COgeminate recombination is very small,
0.05, and it has an absolute error of approximately 0.03,
which is roughly the same for all values of Fgem measured. To
reassure ourselves that the calculated kentry values are valid for
the CerHb mutants, we examined the correlations between
kentry , kNO , and kO2 for some of the key variants (Table 1).
In contrast to CO, the fraction of internal NO recombination
after photolysis is very large, 0.99 due to its high reactivity
with iron. Once inside the protein, NO reacts immediately with
the iron atom, with almost every internal collision between
them being productive. As a result, the rate-limiting step for
NO binding from solvent is the bimolecular rate of ligand entry
into the protein, and the observed association rate constant,
kNO , should equal the calculated value of kentry (Equation 1,
kX  kentry when Fgem3 1.0).
As shown in Fig. 2A, there is a linear correlation between
kentry , calculated using kCO and Fgem,CO, and the experimentally
measured value of kNO for a series of Val-7(B6), Gln-44(E7),
Thr-48(E11), Ala-55(E18), and Leu-86(G12) CerHb mutants
(Table 1). The error in kentry is very large for thosemutants with
large kCO and very small Fgem,CO values, making it hard to
determine the slope of the correlation between kentry and kNO .
In addition, there appears to be a systematic overestimation of
kentry for the CerHb variants with Fgem,CO	 0.1 (Fig. 2A). How-
ever, the correlation is strong for mutants where Fgem is larger
due to partial blockage of the tunnel. Similar linear correlations
between kentry and kNO were observed for all of the SwMb
mutants reported in Scott et al. (13), verifying the kentry values
for myoglobin.
As shown in Fig. 2B, there is a 1:1 correlation between kNO
and kO2 for the CerHb variants in Table 1 implying that O2
binding is also primarily limited by the bimolecular rate of entry
into the protein. The only exceptions are the T48V mutant,
where the loss of -OH at the E11 position releases the phenol
side chain of Tyr(B10), allowing it to sterically inhibit iron-
ligand bond formation, and the Q44F mutation, where the
larger Phe(E7) side chain directly inhibitsO2 binding at the iron
atom. For both these mutants, overall O2 binding is slowed
because bond formation ismarkedly inhibited. As a result, kbond
becomes similar to kescape causing a decrease in kO2 due to a
decrease in Fgem and not the rate of entry (Equations 1 and 2). In
the case of NO, its high reactivity with the iron atom is still
much greater than that of ligand escape, keeping ligand entry as
the rate-limiting step even for the T48V and Q44F CerHb
mutants.
Fig. 2C shows the correspondence between the calculated
ligand entry rate using overall and geminate CO binding data
with the bimolecular rate constant for O2 binding. In this case,
there is an1:1 correspondence with all themutants examined
in this work, even though the scatter is fairly large. All of the
results in Fig. 2 for CerHb and the correlations between kNO
and kentry values for the SwMb mutants (13) support the use of
calculated kentry and kescape values to map ligand pathways and
demonstrate that similar conclusions would be obtained if kNO
or kO2 values were used directly in themapping analysis instead
of the calculated kentry values.
Crystallization, Data Collection, and Refinement of H100F,
H100W, and Y11F/Q44L/T48V/A55W CerHb Variants—The
O2, CO, and aquomet forms of H100F andH100WCerHbwere
crystallized using the sitting drop vapor diffusion method at a
protein concentration of 25mg/ml. The best crystals grew from
solutions containing 2.3 M ammonium sulfate, 100 mM sodium
citrate, pH 5.4, at 277 K. The aquomet form of the quadruple
mutant with an apolar distal pocket was crystallized from solu-
tions containing 200 mM sodium thiocyanate and 2.2 M ammo-
nium sulfate. The O2 and CO forms of this multiple mutant
were obtained by reduction of the ferric crystals in the presence
of either air or 1 atm CO. These manipulations often caused
highmosaicities and reversion to the ferric or completely deox-
ygenated reduced form. As a result, crystal manipulations and
data collection were repeated several times.
In all cases crystals were transferred to appropriate storage
solutions containing 2.8 M ammonium sulfate and 25% sucrose
TABLE 1
Selected rate constants displaying correlations between calculated
rates of ligand entry, kNO
 , and kO2
 in CerHb mutants measured at pH
7.0, 20 °C
Mutantsa kNO kO2 kentry, CO
M1 M1s1 M1s1
WTa 230 30 230 17 640 400
Val-7(B6)
V7A 240 250 450
V7F 110 110 140
V7W 30 33 16
Gln-44(E7)
Q44F 110 20 26
Thr-48(E11)
T48V 80 30 27
Ala-55(E18)
A55V 140 180 260
A55L 47 72 37
A55F 48 61 39
A55W 45 63 34
Leu-86(G12)
L86A 200 230 250
L86F 110 120 150
L86W 68 97 30
Phe-7/Phe-55/Phe-86 32 42 22
a The numbers for WT CerHb are based on the average of all determinations for
the past 6 years (10 separate preparations). As described in the text, the error
in kentry is very large for WT CerHb because Fgem is close to 0.0, poorly defined,
and has an error of60%. When Fgem is0.1, the error in kentry diminishes
greatly to approximately20%. Complete sets of O2 and CO binding
parameters for these and all other variants examined are given in supplemental
Tables S1–S4. Some of the parameters in this table were taken from previous
work (42, 43) or were re-measured.
Mapping Ligand Pathways in Globins
33166 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 287•NUMBER 40•SEPTEMBER 28, 2012
 at R
ICE UNIVERSITY, on M
arch 20, 2013
w
w
w
.jbc.org
D
ow
nloaded from
 
(w/v) immediately before data collection at 100K. ForCOcom-
plexes, the mounting solution was saturated with 1 atm of pure
carbon monoxide.
A cryo-cooling N2 system was used to maintain low temper-
ature (100 K) in the environment of the mounted crystals to
reduce radiation damage. Complete x-ray diffraction data sets
for each of the CerHb variants were obtained from single crys-
tals using CuK radiation (	 1.5418Å) from aRigaku RUH3R
rotating anode x-ray generator operated at 50 kV and 90 mA
and a Rigaku R-AXIS IV image plate detector (Rigaku
Americas Co.). Data were collected, scaled, and reduced using
d*TREK software (54).
The program PHENIX (55) was used for both structure solu-
tion and refinement. The structures of the H100F and H100W
CerHb derivatives (PDB codes 4F6B, 4F6D 4F6F, 4F6G, 4F6I,
and 4F6J) were solved by difference Fourier syntheses using the
structure of wild-type CerHb (PDB code 1KR7) with the ligand
and solvent molecules omitted. The structures of the Y11F/
Q44L/T48V/A55W CerHb mutants (PDB codes 4F68 and
4F69)were also solved by difference Fourier syntheses using the
structure of the A55W CerHb mutant (PDB code 2VYY). An
initial round of simulated annealing was used to calculate unbi-
ased electron density maps to confirm the correct placement of
the mutated residues. This process was followed by several
refinementmacrocycles withmaximum likelihood as the target
and included bulk solvent correction and anisotropic scaling of
the data, individual coordinate refinement with minimization,
and individual isotropic ADP refinement interspersed with
manual fitting. The ligands were modeled into the electron
density maps at this point, and refinement was continued with
restraints imposed on the expected Fe2-CO, Fe2-O2, or
Fe3-H2O geometries. Solvent molecules were then included,
and in a few cases, combined TLS and individual ADP refine-
ments were carried out in the final stages of refinement.
Map fitting and other manipulations with molecular models
were performed using the graphic software COOT (56). The
accession codes for the models, crystal parameters, and statis-
tics of x-ray data collection and refinement are provided in
Table 2. Figs. 1, 4, 5, and 6 were prepared using the PyMOL
Molecular Graphics System, version 1.2r3pre (Schro¨dinger,
LLC).
RESULTS
Mutagenesis Mapping Strategy—The distal pockets, internal
Xe-binding cavities, and tunnels within SwMb and CerHb are
shown in Fig. 1. Key amino acid side chains near the E7 gate
(Gln-44 inCerHb andHis-64 in SwMb), at theXe-binding sites,
and along the apolar tunnel in CerHb between the E and H
helices are shown as sticks and labeled in theupper panelsof Fig.
1. From these side views, it is clear that the continuous apolar
tunnel in CerHb is not present in SwMb due both to the pres-
ence of the A helix and to the occurrence of larger amino acid
side chains located along the interiors of the E, G, andH helices
in SwMb, which separate the various internal Xe cavities.
To define experimentally the ligand entry/exit pathway in
CerHb, we constructed a series of replacements with small (Ala
and Val) to large (Trp and Phe) amino acids at positions in or
along the E7 channel, the apolar tunnel, and other regions
reported to be important, based on previous simulations and
experimental work with recombinant Mbs and Hbs.We exam-
ined 101 single point mutations at 22 different positions in
CerHb, and the overall rate constants for O2 and CO binding
were measured using rapid mixing, laser photolysis methods
with O2/CO mixtures, and flow-flash techniques as described
in Salter et al. (42) and Pesce et al. (43). Internal CO recombi-
nationwithin eachmutantwas alsomeasured using a 7-ns YAG
laser. The rate, kgem, and the fraction, Fgem, of geminate recom-
bination and the overall bimolecular rate constant for CObind-
ing, kCO , were used to estimate the first order rate constant for
ligand escape (kescape  kgem,CO(1  Fgem,CO)) following its
photodissociation from the heme iron and the bimolecular rate
of ligand re-entry from solvent (kentry  kCO /Fgem,CO) (42, 43).
In key cases, the calculated value of kentry was verified by mea-
suring the bimolecular rate constant for NO association as
described under “Experimental Procedures” (Table 1 and Fig.
2). Complete sets of O2 and CO kinetic parameters for all the
CerHb variants examined are listed in the supplemental Tables
S1–S4.
Underlying Assumptions—The first premise of ourmutagen-
esis approach is that larger and smaller apolar amino acid side
chains should impose larger and smaller kinetic barriers,
respectively, for both ligand entry and escape if they are located
along the primary pathway for ligand binding (13, 42). Thus, the
overall bimolecular rate constant of ligand entry for a mutant
with a small amino acid, kentry,small , should be significantly
larger than the entry rate constant for a mutant with a large
amino acid, kentry,large , at positions located along the migration
pathway that leads to bond formation. Similar relationships
should occur for the ligand escape rate constants for the same
set of mutants. To quantify these effects, we computed the
overall rate enhancement effect, Renhance, of a large-to-small
mutation as shown in Equation 3 (13),
Renhance logkentry,smallkentry,large logkescape,smallkescape,large (Eq. 3)
Large-to-small replacements at positions on the major ligand
pathway will increase both kentry and kescape, which will lead to
positive values for both logarithmic terms in Equation 3 and a
large value of Renhance when added together. In contrast, muta-
tions at positions distant from the ligand trajectory should have
little or no effect on entry and escape.
The second premise of our mapping approach is that ligand
binding and single point mutations have only minor effects on
overall globin structure. Ligand binding to Mb does produce
structural changes involving replacement of distal pocket
water, small outward movements of the distal histidine, and
alterations of the proximal pocket andminor tilting of the heme
to accommodate in-plane movement of the iron atom. How-
ever, none of these changes have a significant effect on the over-
all tertiary structure and the internal Xe cavities shown in Fig.
1A (14, 19, 36, 37). Recently, Germani et al. (57) have shown
that CO and O2 binding to deoxy-CerHb causes even smaller
changes in the heme cavity andhas no effect on the size or shape
of the apolar tunnel.
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FIGURE 1. Side views of WT CerHbO2 and SwMbO2. In both globins the molecules are oriented so that the planar heme group is viewed edge-on, its
propionates are facing left and the “distal pocket” is above the heme. Portions of the protein matrix are removed so the interior view is clear. Xe atoms
are depicted as teal spheres; key amino acids and the heme prosthetic groups are indicated by sticks with carbon in green, oxygen in red, and nitrogen
in blue; the remainder of the protein structure is represented as gray spheres. A, upper panel, SwMbO2withmost of the E-helix removed (PDB code 2MGM)
and Xe1 and Xe4 inserted into positions obtained from the metMb structure determined at high Xe pressures (PDB code 2W6W). Key distal pocket
residues include Leu-29(B10), His-64(E7), Val-68(E11), and Phe-43(CD1). Additional mutants constructed in this study include mutations made at
residues Arg-45(CD3), Leu-61(E4), Leu-69(E12), Ile-75(E18), and Leu-135(H12). Middle panel, mechanism for ligand binding to Mb based on Scott et al.
(13, 38). Lower panel, cavity surfaces (gray mesh) in SwMbO2 (PDB code 2MGM), obtained using the surface function in PyMOL, are compared with the Xe
atompositions found inmetMb under high Xe pressures (PDB code 2W6W). As described in Pesce et al. (39), no apolar tunnels were found in SwMb using
Surfnet (64). We also found no tunnel in SwMb usingMOLE online 2.0 (65) using the default settings. The cavities found using PyMOL in SwMbO2 are not
connected. Xe1–Xe4 atoms were inserted into the structure based on their positions in 2W6W. B, upper panel, WT CerHbO2 (PDB code 1KR7) with most
of the E helix removed and bound Xe atoms inserted at their locations in L86A CerHbO2 equilibrated with Xe gas (PDB code 2XKH). Key distal pocket and
apolar tunnel residues include Val-7(B6), Tyr-11(B10), Gln-44(E7), Thr-48(E11), Ala-55(E18), Ala-82(G8), Leu-86(G12), Leu-98(H9), and His-100(H11) in WT
CerHbO2. Middle panel, mechanism for ligand binding to CerHb taken from Salter et al. (42) and Pesce et al. (43). Lower panel, ribbons drawing for WT
CerHbO2 (1KR7) with an apolar tunnel (red mesh) computed using MOLE online 2.0 (65) with a probe radius of 3 and 1.25 Å interior threshold (default
settings). Xe atoms were inserted based on their positions in PDB code 2XKH.
FIGURE 2. Correlation of calculated rates of ligand entry, kNO
 , and kO2
 in CerHb. A, kentry
 versus kNO
 ; B, kO2
 versus kNO
 for Val-7(B6)Ala, -Phe, and -Trp;
Thr-48(E11)Val; Ala-55(E18)Val, -Leu, -Phe, and -Trp; Leu-86(G12)Ala, -Phe, and -Trp; Gln-44(E7)Trp; and Val-7(B6)Phe/Ala-55(E18)Phe/Leu-84(G12)Phe CerHb
mutants (supplemental Table S2). C, kentry
 versus kO2
 , open circles, all singlemutants are located in and along the apolar tunnel (supplemental Table S1); closed
circles, multiple mutants are located in the apolar tunnel (supplemental Table S4).
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Our previous work with distal pocket mutants of CerHb also
showed very little change in overall structure (41), and crystal-
lographic studies of the mutations at the 55(E18) (42) and
100(H11) positions (this report) near the solvent entrance to
CerHb have little effect on overall globin structure or the tun-
nel. In contrast, Xe addition to WT CerHbO2 crystals causes
loss of diffraction, andwe could only determine the structure of
Xe bound to L86A CerHb where the tunnel cavity near the
internal G12 position is enlarged. Similarly, we have been
unable to crystallize V7F, V7W, L86F, and L86W variants pre-
sumably because the larger aromatic side chains expand the
tunnel and unfavorably alter inter-protein contacts in the crys-
tal lattice. However, all standard UV-visible, FTIR, and CD
spectroscopic properties of these tunnel mutants are very sim-
ilar to those of the WT protein.
In addition, mutations near the bound ligand can have
large effects on overall ligand binding parameters due to
either direct steric hindrance of bond formation or electro-
static stabilization of the bound ligand. In most cases, these
effects are manifested as large changes for the internal rate of
iron-ligand bond formation or dissociation (kbond and kbond
in Fig. 1) and do not significantly alter the rates for entry and
escape (13, 38). In some cases, the results can be very com-
plex, particularly for mutants containing Q44H and Q44W
replacements (supplemental Tables S2 and S3) (42). How-
ever, in general, the assumption that single point mutations
are conservative with respect to overall globin tertiary struc-
ture appears to hold for both CerHb and SwMb (33, 36–38,
41–43, 48).
We also constructed and characterized eight new SwMb
mutants to augment the data from Scott et al. (13) and to better
complement the set of CerHb mutants located near the exit
point of its apolar tunnel and at position CD3 near the His(E7)
gate (Table 3). These SwMbmutations included R45W, L61W,
L69A, L69W, I75A, I75W, L135A, and L135W at the CD3, E4,
E12, E18, and H12 helical positions. Estimates of the rates of
entry and escape in SwMb were measured using O2 instead of
CO, as described in Scott et al. (13). The iron atom inMb is less
reactive due to proximal constraints, and as a result, very little
internal CO recombination is observed at room temperature in
ordinary buffers. In contrast, WT Mb shows 50% geminate
O2 recombination, and the rate is slow enough (kgem 10–20
s1, t1⁄230–60 ns) to be measured readily using a 7-ns YAG
laser excitation pulse. In the case of CerHb, O2 geminate
recombination is too fast to measure accurately with WT and
most mutant proteins (kgem130 s1, t1⁄2 5 ns) (42).
Rate Enhancement Maps—Bar graphs of the rate enhance-
ments caused by large-to-small mutations, Renhance, versus
sequence position are shown in Fig. 3 for both SwMb and
CerHb. In both cases, significant effects are observed at the
active site positions where the amino acid side chains interact
directly with bound ligands (see B10, CD1, E7 and E11 bars
labeled with blue diamonds in Fig. 3). However, beyond those
regions the differences between Mb and CerHb are dramatic.
In the case ofMb, large rate enhancements are only observed
at or near the E7 channel or in the back of the distal pocket
where ligands are initially captured before binding to the heme
iron atom, i.e. positions 29(B10), 32(B13), 43(CD1), 46(CD4),
64(E7), and 68(E11). No significant enhancements of the rates
of entry and escape are observed at positions around the Xe1
cavity (i.e. positions 89(F4), 99(FG5), 104(G5), and 138(H15)),
in regions equivalent to the apolar tunnel in CerHb (i.e.
between the E, G, and H helices), or at other remote locations
suggested by previous MD simulations (Fig. 3A). In contrast,
large rate enhancements for entry into and escape from CerHb
are observed for replacements lining the apolar tunnel shown in
Fig. 1B, including positions near the C-terminal ends of the E
and H helices and at position Val-7(B6) where the distal pocket
TABLE 3
Bimolecular, geminate, and calculated rateparameters for newSwMbmutants located at positions near the E7 channel andnear the endsof the
E and H helices measured at pH 7.0, 20 °C
Mutants
Bimolecular binding parametersa
Observed geminate
parametersa Calculated rate parametersa
kO2 kO2 KO2 kgem, O2 Fgem, O2 kbond kescape kentry
M1s1 s1 M1 s1 s1 s1 M1s1
WT 16 3b 14 3 1.1 0.2 12 3 0.47 0.09 5.7 1.0 6.3 1.0 34 7
Arg-45(CD3)
Ala-45 7.7 30 0.26 5.8 0.31 1.8 4.0 25
Trp-45 6.2 21 0.30 10 0.13 1.3 8.7 48
Leu-61(E4)
Ala-61 11 26 0.43 19 0.33 6.6 12 33
Trp-61 8.8 11 0.80 15 0.24 3.6 11 37
Leu-69(E12)
Ala-69 28 13 2.2 22 0.46 10 12 61
Trp-69 13 5.2 2.5 32 0.61 20 13 21
Ile-75(E18)
Ala-75 22 8.5 2.6 16 0.35 5.6 10 63
Trp-75 16 8.8 1.8 16 0.43 6.9 9.1 37
Leu-135(H12)
Val-135 21 8.1 2.6 20 0.40 8.0 12 53
Trp-135 23 6.5 3.5 18 0.33 5.9 12 70
a The values of KO2 were calculated from kO2 /kO2, and its standard deviation was calculated from the standard propagation of error formula. When fitting the O2 geminate
data, single and double exponential fits were examined. In the case of kgem values, estimates from one exponential fits were used initially. In the case of Fgem values, two
exponential fits were used to estimate the total Fgem,O2. Similar values for kentry and kescape were obtained from two exponential analyses as described under “Experimental
Procedures.” Because no significant Renhance values were observed for these mutants, further more sophisticated analyses were not warranted.
b Rate constants in bold are taken from Ref. 13.
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connects to the apolar tunnel (bars labeledwith green asterisks,
Fig. 3B).
The magnitudes of the Renhance parameters are mapped onto
the three-dimensional crystal structures of WT SwMb and
CerHb in Fig. 4 (13). The order of Renhance effects is red 
orange  yellow spheres at native amino acid positions (see
legend to Fig. 4). The white or gray sticks in Fig. 4 indicate
positions where little or no effect is observed on kentry and
kescape for large-to-small amino acid substitutions.
The results are quite clear for both proteins. Only positions
near the E7 gate or in the distal heme pocket are highlighted in
SwMb, and no rate enhancements are observed along alterna-
tive pathways, including the Xe pockets or other interior apolar
regions (Fig. 4, A–C). In contrast, mutagenesis mapping clearly
highlights the internal tunnel in CerHb (Fig. 4, D–F), proving
experimentally that ligands enter and exit through this path-
way. This conclusion is particularly evident in Fig. 4Fwhere the
tunnel between the E and H helices is clearly seen and circum-
scribed by red, orange, and yellow side chains. The same view for
SwMb (Fig. 4C) shows that this pathway is completely blocked
by the A helix.
Identifying the Solvent Exit of the Apolar Tunnel—Three fur-
ther tests of the apolar pathway in CerHb were performed.
First, we explored the solvent-exposed exit aperture of the apo-
lar tunnel at the ends of the E and H helices; second, we exam-
ined the influence of polar interactions at the E7 gate; and third,
we filled the apolar channel with aromatic amino acid side
chains to completely block this pathway.
InWTCerHbO2, the polar imidazole side chain ofHis-100 at
the H11 helical position is extended out into solvent and does
not appear to block entry into the protein (Figs. 1B and 5B) (42).
As expected, removing the imidazole at this position by a
H100A mutation has little effect on ligand binding; however,
both Phe and Trp mutations at this position cause 3-fold
decreases in both kO2 and kO2, with little change in affinity
(Table 4). These same aromatic amino acid mutations also
cause large increases in the fraction of CO geminate recombi-
nation, from 0.05 for WT CerHbCO to 0.34 for H100W
(Fig. 5A), and a marked decrease in kgem,CO due to an10-fold
decrease in kescape (Table 4). All of these effects suggest that
large Phe and Trp side chains at the H11 helical position in
CerHb rotate back to the protein surface to partially cover the
solvent exit of the ligand tunnel and restrict ligand escape.
The imidazole ring of the naturally occurring His-100 side
chain is poorly defined in theWTCerHbO2 structure, with only
a portion of the expected electron density of the ring apparent
in the calculatedmap (Fig. 5B). In the structures containing the
A55W replacement, the His-100 chain is better defined but in a
different orientation due the large indole ring at the E18 posi-
tion, which restricts the motion at the H11 helical position (i.e.
see Fig. 6C). Fig. 5C shows the conformation ofHis-100 in seven
different CerHb structures in both reduced and oxidized forms.
The side chain appears to show free rotation about the C–C
bond with no specific energyminimum, presumably because of
equally favorable interactions with solvent water molecules. As
a result, the entrance into the apolar channel is kept open.
When Phe or Trp is inserted into this position, the more apolar
aromatic rings appear to be forced into the entrance of the
channel by a hydrophobic effect and restrict ligand entry and
escape (Table 4 and Fig. 5A).
To verify this interpretation, we crystallized and determined
structures of the H100F and H100W CerHb mutants in
FIGURE3.EffectsofAlaorVal toPheorTrpmutationsonentryandescape inCerHbandSwMb.Bluediamondsdenotehelical positions typically associated
with the E7 gate pathway.Green asterisks are associatedwith positions along the apolar tunnel pathway. Data for SwMbwere taken from this study andRef. 13.
The enhancement factor, Renhance, on the y axis is defined in Equation 3, and the topological helical position is given along the x axis.
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reduced O2- and CO-bound forms and in the oxidized state
(Table 2). In both cases, the aromatic side chains rotated back
onto the protein surface, partially entering and blocking the
tunnel from theH11helical position (Fig. 5D). TheTrp-100 and
Phe-100 side chain conformations have100% occupancy, are
well defined by electron density (Fig. 5D), and account for the
decreases in rates of ligand entry and exit and the increase in
geminate CO recombination observed for H100F and H100W
mutants (Table 4 and Fig. 5A).
In WT CerHb, the small residue Ala-55 at E18 is located on
the opposite side of the entrance to the apolar channel from
His-100 at H11. Substitution of a Trp for Ala at this position
also blocks ligand entry, decreases kentry and kescape, and traps
photodissociated ligands inside the protein, increasing Fgem
(Table 4 and Figs. 3B and 6C) (42). Similar large decreases in
kentry and kescape and increases in Fgem occur when Ala-101 at
H12 is replaced with Trp (Fig. 3B and supplemental Table S1).
Combined, thesemutagenesis results unambiguously locate the
entrance for ligand movement into CerHb between the ends of
the E and H helices at positions E18, H11, and H12.
Constructing an Apolar Distal Pocket—Pesce et al. (39, 43)
suggested that extensive polar interactions between Tyr-
11(B10), Gln-44(E7), Lys-47(E10), and Thr-48(E11) limit open-
ing of the E7 gate, causing ligands to use the apolar tunnel for
entry and exit. To test this idea, we examined ligand binding to
a triple CerHbmutant with a completely apolar active site con-
FIGURE4.Mapsof theeffectsof large-to-smallmutationsontherateofentryandescape inSwMb(PDBcode2MGK)andCerHb(PDBcode1KR7).Theprotein
backbones are represented as silver ribbons, and the heme groups are shown as blue sticks. A–C, side, top, and back views of SwMb.D–F, side, top, and back views of
CerHband its ligand tunnel.Red spheres signifyRenhance1.5;orange spheres signify 1.5Renhance1.0; yellowspheres signify 1.0Renhance0.5;whiteorgray sticks
signify 0.5 Renhance (no significant effect). Numerical values are shown in Fig. 3 (13) and can be computed from the supplemental tables.
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FIGURE5.His-100 isat theentrance to theapolar tunnel inCerHb.A, timecourses forgeminate recombination inHis-100(H11)mutantsofCerHbCOat20 °C,
pH 7.0. The fraction of geminate recombination increases 6-fold uponmutating the polar His to large aromatic amino acids. B, 2Fo Fc electron density maps
for Ala-55(E18) cutoff at 1.5 
, and His-100(H11) cutoff at 0.7 
 in WT CerHbO2 (PDB code 1KR7). The polar imidazole side chain of His-100 at the H11 helical
position is poorly defined, cannot be seen at the higher contour levels, and appears to extend out and interact with solvent molecules, keeping the
channel open. C, positions of the His-100(H11) side chain in the structures for the O2 and aquomet complexes of WT CerHb (PDB codes 1KR7 and 2XKI), L86A
CerHbO2 Xe (PDB codes 2XKG and 2XKH), T48V CerHbO2 (PDB code 1V07), A55W CerHbO2 (PDB code 2VYY), and A55F CerHbO2 (PDB code 2VYZ). D, 2Fo
Fc electron density map for the Trp-100(H11) cutoff at 1.5 
 in H100W CerHbO2 (PDB code 4F6I). The indole side chain is well defined.
TABLE 4
Key rate and equilibrium parameters for O2, CO, and NO binding to wild-type and selected mutants of CerHb at pH 7, 20 °C
CerHb varianta kO2 kO2 KO2 kCO Fgem, CO kentry (kNO ) kescapeb
M1s1 s1 M1 M1s1 s1
WT 230 17 190 25 1.2 0.2 32 5 0.05 0.03 640 400 (270) 76 40
H100A 210 230 0.93 30 0.05 570 72
H100F 99 110 0.90 17 0.29 59 14
H100W 77 92 0.84 17 0.34 50 7.0
Y11F/Q44L/T48V 340 270 1.6 165 0.40 410 44
Y11F/Q44L/T48V/A55W 70 50 1.4 27 0.85 30 7.5
V7W/Y11F/Q44L/T48V 82 54 1.5 40 0.77 52 22
WT 230 17 190 25 1.2 0.2 32 5 0.05 0.03 640 400 (270) 76 40
V7A 250 270 0.93 36 0.08 450 (240) 30
L86A 230 150 1.5 25 0.10 250 (200) 21
V7A/L86A 240 190 1.3 35 0.14 255 7.3
V7F 110 115 0.97 22 0.16 135 (110) 54
V7W 33 14 2.4 13 0.82 16 (30) 13
L86F 120 71 1.7 24 0.17 140 (110) 77
L86W 97 60 1.6 16 0.54 30 (68) 36
A55F 61 51 1.2 17 0.44 38 (48) 5.0
A55W 63 66 0.95 15 0.44 34 (45) 5.0
V7F/L86F/A55F 42 17 2.5 17 0.79 20 (32) 8.2
V7W/L86W/A55W 23 3.0 7.6 7.2 0.93 8 4.1
a Complete sets of association and dissociation rate parameters and equilibrium constants for CO and O2 binding to these variants and others are given in supplemental
Tables S1–S4.
b The values in parentheses in the second-to-last column are the values for kNO , the bimolecular association rate constant for NO binding, which should approximate the
computed rate of ligand entry, kentry (see supplemental Table S1). The errors in kentry and kescape for WT CerHb are very large due to the small value of Fgem, and this
problem and the validity of the calculations are discussed under “Experimental Procedures.”
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taining Y11F/Q44L/T48V mutations at the B10, E7, and E11
helical positions, respectively. As shown in Table 4, rates of O2
binding to and dissociation from this triple mutant increase by
only 50%, and there is little change in the computed values of
kentry and kescape compared with WT CerHb. The extent of
geminate recombination does increase to0.40 (Fig. 6A) due to
a marked7-fold increase in the rate of covalent bond forma-
tion (kbond) comparedwithWTCerHb (from4.0 to30s1
for themutant, see supplemental Table S4). However, when the
A55W mutation is added to this triple mutant to block exit
from the apolar tunnel (Fig. 6C), there are marked 5-fold
decreases in kO2 and kO2; the fraction of geminateCO rebinding
increases to 0.85, and the calculated value of kentry decreases
from400 to30 M1 s1 (Table 4 and Fig. 6A). Thus, even
when the distal pocket is made apolar, ligands still appear to
enter and exit the protein through the apolar tunnel, and block-
ing the entrance to the tunnel markedly inhibits bimolecular
binding.
We determined the crystal structure of the Y11F/Q44L/
T48V/A55W mutant to examine whether the apolar substitu-
tions cause significant changes in the tertiary structure of
CerHb. Electron density maps for the active site amino acids of
the quadruple mutant and Trp-55 at the tunnel entrance are
shown in Fig. 6, B and C, respectively. A comparison of the
active site of the quadruple mutant to that of the single A55W
mutant is shown in Fig. 6D. The structures overlay remarkably
well with a root mean square deviation of 0.17 Å for the C
atoms, and the side chains of the B10, E7, and E11 amino acids
have very similar conformations despite the changes in polarity
(note that the rootmean square deviationwas 0.15 Å for the C
atoms of WT CerHb and the quadruple mutant). The major
difference is that there is more “free” space surrounding the
bound O2 atoms due to the loss of the O atom of Tyr-11(B10)
and the N or O atoms of Gln-44(E7). This loss of steric hin-
drance adjacent to the bound ligand accounts for the increase in
the rate and fraction of geminate recombination after laser pho-
tolysis (Fig. 6A and Table 4). Instead of being pushed away by
the larger Tyr(B10) and Gln(E7) side chains, photodissociated
CO can remain near the center of the heme group and more
rapidly rebinds than in WT CerHb. However, the large, 10-
FIGURE 6. Effects of an apolar active site on the structural and geminate recombination properties of CerHbCO. A, geminate rebinding in multiple
mutants of CerHbCO with an apolar distal pocket containing Y11F/Q44L/T48V mutations at the B10, E7, and E11 helical positions, respectively, and Trp
replacements at the Val-7(B6) andAla-55(E18) tunnel positions. B, 2Fo Fc electron densitymaps cutoff at 1.5
 for the hemegroup, axial ligands, Phe-11(B10),
Leu-44(E7), and Val-48(E11) in Y11F/Q44L/T48V/A55W CerHbO2 (PDB code 4F68). As shown, all three side chains are very well defined. C, 2Fo  Fc electron
density maps for Trp-55(E18) cutoff at 1.5 
 and His-100(H11) cutoff at 1.0 
 in Y11F/Q44L/T48V/A55WCerHbO2 (PDB code 4F68). The side chain for His-100 is
lesswell defined comparedwith the indole ringof Trp-55.D, comparisonof the active sites of A55WandY11F/Q44L/T48V/A55WCerHbO2. TheC atomsof the
structures for A55W (PDB code 2VYY) and quadruple CerHbO2mutant (PDB code 4F68) were superimposed in PyMOL. The heme and active site side chains of
the Y11F/Q44L/T48V/A55WCerHbO2mutant are drawn as green sticks,whereas the heme and active site polar side chains of A55WCerHbO2 are drawn in CPK
colors, with carbon, oxygen, nitrogen, and iron atomsbeing gray, red, blue, and orange, respectively. Positions 11, 44, 48, and 55 correspond to the B10, E7, E11,
and E18 helical locations in the globin fold.
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fold decrease in the rate of entry caused by the A55Wmutation
at E18, even when the active site is apolar, argues strongly that
most ligands (90%) still enterCerHb through the apolar chan-
nel (kentry values in Table 4).
Completely Blocking the Tunnel—As a final test of the map
for CerHb, we attempted to completely block ligandmovement
through the apolar tunnel. To prove that entry into the distal
pocket from the tunnel is at the B6 position, we mutated Val-
7(B6) to Ala, Phe, and Trp. As shown in Fig. 7, introducing an
indole ring at this position traps CO inside the distal pocket
increasing both Fgem and kgem dramatically. At the same time,
the V7W replacement markedly decreases kentry , kO2 , and kNO
and the rate of O2 dissociation (Table 4), demonstrating that
this position is on the pathway for ligand binding. This conclu-
sion is verified by the large increase in Fgem and a decrease in
kentry when the V7W mutation is added to the apolar pocket
(Y11F/Q44L/T48V) CerHb mutant (Fig. 6A and Table 4).
The V7A/L86A CerHb double mutant was constructed as a
control for a completely open channel with Ala at the three key
positions along the apolar tunnel, 7(B6), 55(E18), and 86(G12),
respectively (WTCerHbhasAla at position 55(E18)). This dou-
ble mutant has kinetic parameters very similar to those of
WT CerHb (Table 4). In contrast, the V7F/A55F/L86F and
V7W/A55W/L86W triple mutants show dramatic 10-fold
decreases in kO2 , kO2, and kentry and 10-fold increases in
Fgem,CO, from 0.05 for WT CerHb to 0.80 and 0.93 for the
triple Phe and Trp mutants, respectively (Table 4 and Fig. 7).
The computed Renhance value comparing Ala-7/Ala-55/Ala-86
versus Trp-7/Trp-55/Trp-86 is 3.1, indicating a 3-fold increase
in the free energy barrier to ligand escape and entry. These data
show unambiguously that the apolar tunnel in CerHb can be
closed bymutagenesis, reducing themeasured bimolecular rate
constants for O2 and NO binding and the calculated rate for
ligand entry to less than 10% of the WT values.
DISCUSSION
Single versus Multiple Pathways—The experimental mu-
tagenesis results in Figs. 2–7, Table 4, and supplemental Tables
S1–S4 are very clear. Ligands enter and exit CerHb through the
apolar tunnel as originally suggested by Pesce et al. (39). When
three Phe or Trp replacements at positions 7(B6), 55(E18), and
86(G12) are used to fill the entire tunnel, the bimolecular rate of
ligand entry decreases dramatically. An estimate of the rate of
ligand entry when the apolar channel is closed was calculated
from the average of the kentry , kNO , and kO2 values for the V7F/
A55F/L86F and V7W/A55W/L86W mutants (Table 4) and is
25 12M1 s1. An estimate of the value for ligand entry into
CerHb with an open tunnel was computed from the average of
the kentry , kNO , and kO2 values for WT CerHb and the V7A,
L86A, and V7A/L86A mutants (Table 4) and is equal to 300
130 M1 s1.
If the triple aromatic mutations at the B6, E18, and G12 he-
lical positions completely close the tunnel, the residual bimo-
lecular rate of 25 M1 s1 applies to ligand binding through
alternative routes. This value suggests that inWTCerHb92%
of the ligand molecules enter through the apolar tunnel and
only 8% by alternative routes. Interestingly, when the tunnel is
blocked, the value of kentry is only slightly smaller than the esti-
mated rates of ligand entry into WT (His-64(E7)) and Gln-
64(E7) SwMb, which are 34 and 60 M1 s1, respectively
(13). Thus, the limiting value of 25 M1 s1 for the triple aro-
matic CerHb mutants could represent ligand movement
through the Gln(E7) gate, although this conclusion is
speculative.
In the case of SwMb, all the positions that regulate entry and
escape are located in the distal pocket or at the heme propi-
onate-solvent interface (Figs. 3 and 4, A–C). As pointed out by
Scott et al. (13) and Olson et al. (38), when the effects of Xe
binding and selected mutations are examined individually, the
arguments in favor of ligandmovement through the E7 gate are
even stronger. There are no changes in the fraction of geminate
O2 recombination, the calculated bimolecular rate constants
for ligand entry, or the observed association rate constants for
O2 and CO binding to WT SwMb when the protein solution is
pressurized with 5–10 atm of Xe. Similarly, when Trp substitu-
tions are made in the Xe1 and Xe4 sites, there are small or no
changes in kentry , kescape, and Fgem (13, 38).
The E7 gate pathway in SwMb is also supported strongly and
independently by time-resolved x-ray crystallography mea-
FIGURE 7.Time courses for geminate recombination inmultiple tunnelmutants of CerHbat 20 °C, pH7.0.A,COgeminate rebinding in position Val-7(B6)
mutants of CerHb.B,COgeminate rebinding in single, double, and triple Phemutants inpositionsVal-7(B6), Ala-55(E18), andLeu-86(G12)mutants of CerHbCO.
C, CO geminate rebinding in single, double, and triple Trp mutants in positions Val-7(B6), Ala-55(E18), and Leu-86(G12) mutants of CerHbCO.
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surements with mutants at the 29(B10) position. The lifetimes
of CO in the Xe1 pockets of WT, L29F, and L29W SwMb are
2–10 s (19), 100–300 s (14, 18), and 1–2 ms (16), respec-
tively, and the double mutant L29Y/H64Q SwMb shows inter-
mediate behavior (15). If ligandsmoved directly to solvent from
the Xe1 site, the size of the amino acid at the B10 position
should have had no effect on the lifetime for ligand escape from
this position. Instead, ligands appear to move back to the distal
pocket, pass between the B10 side chain and the plane of the
heme, and then exit through the E7 channel.
When His-64(E7) is replaced with Trp in SwMb, the calcu-
lated bimolecular rate of entry decreases from34 to 7M1 s1,
implying that up to 25% of the ligandmolecules may take alter-
native routes to the active site (13). However, this calculation
assumes that the H64W substitution completely blocks the E7
channel. Recently, Birukou et al. (52) have shown that the
indole side chain in the crystal structure of H64W deoxy-Mb
does not enter the E7 channel but just partially blocks the
entrance, occupying a position between the heme propionates.
A similar “blocked” conformation is observed in the crystal
structure of Trp-63(E7)  human HbCO subunits (52). In con-
trast, the E7 indole side chain in the crystal structure of Trp-
58(E7) deoxy- human Hb subunits is located in the distal
pocket, completely closing the E7 channel and sterically
restricting access to the heme iron (52). In this completely
“closed” conformation, the Trp(E7) side chain causes 100-
fold decreases in both kNO and the calculated value of kentry for
isolated mutant  subunits (49, 52). Thus, it is possible that the
percentage of ligands entering through the E7 channel inMb is
significantly larger than the 75% value estimated from the rate
of entry for Trp-64(E7) MbO2.
Discrepancies withMDSimulations—Themutagenesismap-
ping results in Figs. 3 and 4 are not in agreementwith either past
or recent molecular dynamics simulations, all of which suggest
multiple pathways. The latest theoretical work for both CerHb
and SwMb suggests 3–5 pathways with roughly equal probabil-
ities, one of which is the E7 channel in the case of SwMb and the
apolar tunnel in CerHb. Thus, the theoretical calculations pre-
dict that 20–33% of the ligands enter and exit through the
paths identified experimentally by mutagenesis, implying that
alternative routes show similar rates of entry. In contrast, the
experimental data indicate that ligand movements through the
E7 gate in SwMb and the apolar channel in CerHb are4–10-
fold faster than through the alternative routes, based on the
much smaller measured bimolecular rate constants when the
gate or tunnel is blocked by Trp side chains. However, these
differences are relatively small on a free energy of activation
scale. Thus, small inaccuracies in representing chemical and
structural barriers along the individual pathways could easily
affect the computed results.
One key problem is representing the barrier to apolar ligand
movement through clathrate-likewater clusters that cover apo-
lar patches at the protein surface. For example, well defined
crystallographic water molecules surround the highly con-
served Leu-89(F4) side chain in SwMb, which is apolar and
protects the iron-His-93(F8) bond from being hydrated (33).
We mutated this amino acid to Gly to open a hole into the Xe1
cavity and observed that a string of 3 to 4 water molecules
entered this site and were connected to well defined surface
waters, forming an extended chain of “ice-like” structures (33).
The rates of bimolecular ligand binding and unimolecular
release were relatively unaffected by this mutation, and there
was little or no effect on the total fraction of O2 geminate
recombination, even though the Xe1 cavity was completely
open to solvent. The only major change was the loss of the slow
phase for geminate rebinding, which in WT SwMb reflects
movement into and then back from the Xe1 cavity (13). These
structural and computational results demonstrate that water
enters into the exposed Xe1 cavity in the Gly-89(F4) SwMb
mutant and forms a barrier that prevents diatomic apolar
ligands from entering this site.
Another example of how the hydrophobic effect can influ-
ence ligand binding is the effect of the His-100(H11) to Phe and
Trp mutations on ligand binding to CerHb (Fig. 5). In most of
the published structures of WT and mutant CerHb, the imid-
azole side chain of His-100 is pointing directly out into the
solvent (see Figs. 1B and 5, B and C). However, when this polar
amino acid is replaced by Phe and Trp, the hydrophobic effect
pushes the more apolar phenyl and indole rings back on the
surface of the protein, which partially blocks the tunnel
entrance, markedly increases Fgem,CO by trapping ligands
within the CerHb tunnel, and decreases both kentry and kescape
(Fig. 5 and Table 4).
A key test of the accuracy of theoretical calculationswould be
to examine the effects of the L89G SwMb and H100W CerHb
mutations on simulated structures, starting from the WT pro-
teins, and on ligand trajectories, carefully looking at water
structure in and around the Mb Xe1 cavity near the F4 helical
position and the exit aperture of theCerHb tunnel near theH11
helical position. Other valuable tests would be simulations of
the effects of the F46V SwMbmutation at the CD4 helical posi-
tion on movement of the His-64(E7) side chain and of the
motions of the indole side chain in Trp-64(E7) Mb. The F46V
mutation accelerates ligand entry and release in SwMb and
causes outward movement of the distal histidine (34). The
H64Wmutation slows ligand entry4-fold, even though only
the entrance to the E7 channel is blocked (13, 52). The effects of
all four of thesemutations on ligand entry rates are well defined
experimentally and should be replicated in any molecular
dynamics simulation.
Physiological Relevance—Ironically, the fastest rates of ligand
uptake and release are observed when the longer apolar tunnel
in CerHb is used rather than the shorter E7 gate channel inMb.
The rates of ligand binding to CerHb are close to diffusion-
controlled and very similar to model heme compounds with no
distal steric hindrance or to SwMb and human Hb mutants in
which the distal histidine is replaced by Gly or Ala. Thus, the
Nemertean mini-Hb from C. lacteus is able to take up and
releaseO2 roughly 10 timesmore rapidly thanmammalianMbs
andHbs. CerHb surrounds the sea worm’s brain and axons and
acts as an O2 storage protein. High rates of O2 release give the
worm an advantage for high neuronal activity under hypoxic
conditions in the sea floor when it hunts for prey (40).
Apolar tunnels have also evolved in the truncated HbN from
Mycobacterium tuberculosis (MtTrHbN) to facilitate rapid
dioxygenation of NO as part of the bacterium’s defense against
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host macrophages (58–63). In this case, there appear to be two
channels that allow rapid access to the heme iron atom, a short
one between the G andH helices and a longer one leading from
the solvent interface at the AB and GH loops into the distal
pocket (59). The rate constants for bimolecular CO and O2
binding to MtTrHbN become similar to or greater than those
for CerHb when steric restrictions due to distal pocket water
are removed by apolar distal pocket mutations, and the rate of
NO dioxygenation of wild-type MtTrHbN-O2 is 750 M1
s1, which is10-fold greater than that for either humanHbO2
or mammalian MbO2 (61). Both results indicate that, like in
CerHb, ligands can move freely into the active site of
MtTrHbN. Simulations have suggested that Phe-62(E15) closes
the shorter tunnel when O2 is bound, but NO can still rapidly
enter the protein through the longer pathway (60). However,
these ideas are controversial (62, 63) but could be verified or
refuted by mutagenesis mapping approaches similar to those
shown in Figs. 3 and 4.
Conclusions—The experimental mutagenesis mapping re-
sults shown in Figs. 3 and 4 are unambiguous. Ligands enter and
exit CerHb through the interior apolar tunnel at least90% of
the time, whereas ligands enter SwMb from the opposite direc-
tion75% of the time through the E7 gate. The significance of
these results is 3-fold. 1) Our rational mutagenesis mapping
strategy is robust and can identify interior apolar pathways. 2)
Globins have evolved different routes for ligand entry, and the
longer butmore open apolar pathway allowsmore rapid rates of
entry and exit. 3) The SwMb and CerHb results provide exper-
imental benchmarks for testing the validity of molecular
dynamics trajectories, one with a short pathway between the
heme propionates that is gated by a polar residue and another
with an internal route from the heme pocket to an opening at
the opposite end of the protein.
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